CTRI/2022/04/041923已完成2 期
Double-blind, randomized, placebo-controlled efficacy trial of individualized homoeopathic medicines in toothache
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients suffering from enlargement of alveolar ridge NOS, insufficient anatomic crown height, insufficient clinical crown length, irregular alveolar process, toothache NOS (ICD-10 code K08.89)
- •2. Patients suffering from toothache due to injury, dental caries, dental abscess, periodontitis, eruption of teeth, etc.
- •3. Age between 18 and 65 years
- •4. Patients of either sex
- •5. Habit of brushing teeth with toothbrush and fluoridated toothpaste at least once daily
- •6. Literate patients; ability to read English and/or Bengali and/or Hindi
- •7. Providing with written informed consent
排除标准
- •1. Other orofacial pain conditions of non-odontogenic origin
- •2. Recent steroid or antibiotic therapy for dental pain, gingivitis, periodontitis, etc.
- •3. Spontaneous bleeding gum associated with systemic disorder
- •4. Patients who are too sick for consultation
- •5. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure
- •6. Pregnant and puerperal women, lactating mothers
- •7. Vulnerable population – unconscious, ambulatory, too sick for consultation, differently abled, terminally or critically ill patients, institutionalized subjects, mentally incompetent people
- •8. Habit of tobacco chewing, smoking and different other form(s) of substance abuse and/or dependence
- •9. Self-reported immune-compromised state
- •10.Already undergoing homoeopathic treatment for chronic disease within last 2 weeks
研究者
相似试验
已完成
2 期
Homeopathic treatment of breast lumpsCTRI/2022/04/041949D N De Homoeopathic Medical College Hospital63
进行中(未招募)
1 期
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering TherapyEUCTR2005-003511-75-SKDaiichi Sankyo Pharma Development200
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering TherapyPediatric Heterozygous Familial Hypercholesterolemia (heFH)MedDRA version: 8.1Level: LLTClassification code 10057079Term: Heterozygous familial hypercholesterolemiaEUCTR2005-003511-75-CZDaiichi Sankyo Pharma Development200
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering TherapyEUCTR2005-003511-75-HUDaiichi Sankyo Pharma Development200
进行中(未招募)
不适用
Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Colesevelam HCl Administered to Pediatric Patients with Heterozygous Familial Hypercholesterolemia on a Stable Dose of Statins or Treatment Naïve to Lipid-Lowering Therapy - WEL-410EUCTR2005-003511-75-ATSankyo Pharma Development (SPhD)200
